Three individuals, along with the group accused of supplying the peptides, were fined between $5,000 and $10,000 for their ...
Eli Lilly warns compounded tirzepatide mixed with B12 may contain impurities and safety risks as FDA tightens GLP-1 rules—get the latest updates now.
Compounded weight-loss drugs that contain vitamin B12 and the ‌main ingredient in Eli Lilly's Zepbound could present health risks to consumers due to a previously unidentified impurity caused in the ...
Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits, and ...
The modern global health and wellness landscape is undergoing a profound transformation, driven by an increasing consumer demand for natural, effective, and sustainably sourced ingredients. As ...
The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.
Our most recent round of baby formula tests detected contaminants at potentially concerning levels in 26 of the 49 baby ...
This course prepares you for employment within the pharmacy industry where sterile products are made. Course work includes basic skills for aseptic technique, methods of practical production of ...
The MarketWatch News Department was not involved in the creation of this content. Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient ...
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...
Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...
GILBERT, Ariz., Jan. 14, 2026 /PRNewswire/ -- Strive Compounding Pharmacy, one of the nation's most celebrated providers of compounded medications, has filed a federal antitrust lawsuit against ...